Allegheny Technologies (ATI) came out with quarterly earnings of $0.60 per share, missing the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $0.55 per share a year ago.

ATI Announces Third Quarter 2024 Results

07:30am, Tuesday, 29'th Oct 2024
Ninth consecutive quarter with sales in excess of $1 billion Q3 2024 sales of $1.05 billion Q3 2024 net income attributable to ATI of $82.7 million, or $0.57 per share Aerospace & defense represent 62
Allegheny Technologies (ATI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BOLINGBROOK, Ill. , Oct. 21, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. – ("ATI" or the "Company") (NYSE: ATIP), a nationally recognized outpatient physical therapy provider in the United State
ATI-1701 provides full protection against lethal tularemia in animal models after one year Company to provide update on tularemia vaccine candidate ATI-1701 and present new data on efficacy Presentati
Allegheny Technologies (ATI) reachead $63.02 at the closing of the latest trading day, reflecting a +0.75% change compared to its last close.
--(BUSINESS WIRE)-- #HighSchoolVoterRegistration--SEE DEMOCRACY IN ACTION: MULTIPLE ALLEGHENY COUNTY HIGH SCHOOLS CONDUCT VOTER REGISTRATION DRIVES THIS WEEK.
The latest trading day saw Allegheny Technologies (ATI) settling at $62.83, representing a -1.83% change from its previous close.
The latest trading day saw Allegheny Technologies (ATI) settling at $65.59, representing a -0.56% change from its previous close.
DALLAS , Oct. 1, 2024 /PRNewswire/ -- ATI (NYSE: ATI) has scheduled the live webcast for its third quarter 2024 earnings conference call on Tuesday, October 29, 2024, at 7:30 a.m. CT (8:30 a.m.
Allegheny Technologies (ATI) concluded the recent trading session at $65.32, signifying a -0.15% move from its prior day's close.
In the latest trading session, Allegheny Technologies (ATI) closed at $63.84, marking a -1.3% move from the previous day.
Aclaris Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor for the Trea
The latest trading day saw Allegheny Technologies (ATI) settling at $61.77, representing a -0.69% change from its previous close.
Allegheny Technologies (ATI) reported earnings 30 days ago. What's next for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE